Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

Laboratory Report

Patient
Name: Harrison, , Roy,
DOB: 02-OCT-1969 (Age: 56)
Gender: male
Address:
Flat 4
Dyer route
BA1 Baileyville (United Kingdom)
ID: 7093-553922-4 (ECI)
Report
Date: 24-MAR-2020
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 24-MAR-2020

Chemistry

Test 24-MAR-2020 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 7.0 H 4.6 - 6 %
Glucose [Mass/volume] in Blood 105.3 H 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 9.5 7 - 50 mg/dL
Creatinine [Mass/volume] in Blood 1.3 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 138.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 103.5 98 - 114 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.9 22 - 32 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 204.6 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 185.1 H 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 119.5 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 48.1 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 14.4 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The results indicate suboptimal glycemic control (elevated HbA1c and fasting glucose), and dyslipidemia (high total cholesterol and triglycerides). Renal function, electrolytes, and microalbumin/creatinine ratio are within normal limits. Recommend clinical follow-up for diabetes and lipid management to reduce cardiovascular risk.